FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “NEXICLON”, which is offered here for Extended release tablets, extended release chewable tablets and suspension for oral administration of the drug clonidine, intended for the treatment of hypertension, tourette's syndrome, attention deficit hyperactivity disorder and autism;next i clonidine;.
Its status is currently believed to be active. Its class is unavailable. “NEXICLON” is believed to be currently owned by “TRIS PHARMA, INC.”
| Owner: |
TRIS PHARMA, INC.
Owner Details |
|---|---|
| Description: |
Extended release tablets, extended release chewable tablets and suspension for oral administration of the drug clonidine, intended for the treatment of hypertension, Tourette's syndrome, attention deficit hyperactivity disorder and autism;NEXT I CLONIDINE;
|
| Categories: | EXTENDED RELEASE TABLETS |